Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

July 21, 2015

GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis

July 8, 2015

NIDA tests AZD-8529 for smoking cessation

July 7, 2015

Invion completes dosing in phase II trial of oral INV-102 in smoking cessation

July 1, 2015

BARDA exercises additional contract funding for AEOL-10150

July 1, 2015

NIAAA initiates trial of Horizant for alcohol use disorder

June 29, 2015

Laboratorio Farmaceutico CT patents gamma-hydroxybutyric acid prodrugs

June 22, 2015

Pre-EUA dossier for Cleveland Biolabs' entolimod submitted to FDA

June 16, 2015

Probuphine noninferior to sublingual buprenorphine in phase III trial in opioid dependence

June 9, 2015

AEOL-10150 doubles survival in primate model of radiation-induced lung injury

May 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...